Cancer Care Disparities during the COVID-19 Pandemic: COVID-19 and Cancer Outcomes StudyAndrew Schmidt, Deborah B. Doroshow, Ziad Bakouny et al.|Cancer Cell|2020Cited by 72
Oncology clinical trial disruption during the COVID-19 pandemic: a COVID-19 and cancer outcomes studyZiad Bakouny, Deborah B. Doroshow, C. Labaki et al.|Annals of Oncology|2022Cited by 33
Effect of concurrent beta-blocker use in patients receiving immune checkpoint inhibitors for advanced solid tumorsGeorge Mellgard, Che‐Kai Tsao, Emily J. Gallagher et al.|Journal of Cancer Research and Clinical Oncology|2022Cited by 23
Clinical factors associated with outcome in solid tumor patients treated with immune-checkpoint inhibitors: a single institution retrospective analysisQian Qin, Che‐Kai Tsao, Tomi Jun et al.|Discover Oncology|2022Cited by 12
Using EGFR amplification to stratify recurrent glioblastoma treated with immune checkpoint inhibitorsJoshua Friedman, Adı́lia Hormigo, Tomi Jun et al.|Cancer Immunology Immunotherapy|2023Cited by 9